Emerging Biotechs, Small & Mid-Size CROs: We Now Have a Concentriq LS Package for You
Editor2025-08-27T16:00:55+00:00By Ritida Nanda Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire pathology for precision medicine, we’re fully empowering them with our Concentriq LS platform. Trusted by 16 of the top 20 pharmaceutical companies, [...]









